Skip to main content
. 2016 Mar 28;5(3):e002688. doi: 10.1161/JAHA.115.002688

Figure 3.

Figure 3

Absolute risk reduction (Y‐axis on a 0 to 1 scale) by perindopril across different levels of clinical (X‐axis) and pharmacogenetic risk. PGXscore indicates pharmacogenetic risk score.